These innovative treatments, Tirzepatide , represent a remarkable advancement in treating type 2 diabetes and possibly associated conditions . They are grouped as GLP-1 pathway agonists , signifying they to emulate the body's GLP-1 peptide, stimulating metabolic secretion and suppressing food int